Japan Biologics Market Size, Share, and COVID-19 Impact Analysis, By Source (Microbial, Mammalian, and Others), By Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), By Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), and Japan Biologics Market Insights, Industry Trend, Forecasts to 2035
Industry: Healthcare
Need help to buy this report?
Inquiry Before Buy